What are the criteria for removal of an Implantable Cardioverter-Defibrillator (ICD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Criteria for ICD Removal

Complete device and lead removal is mandatory for all patients with definite ICD infection (valvular/lead endocarditis or sepsis), pocket infection (abscess, erosion, skin adherence, chronic draining sinus), valvular endocarditis without definite lead involvement, or occult staphylococcal bacteremia. 1

Infectious Indications (Class I Recommendations)

Definite ICD Infection

  • Valvular and/or lead endocarditis confirmed by transesophageal echocardiography showing vegetations 1
  • Sepsis with positive blood cultures and no other identified source 1

Pocket Infection

Complete removal is required when any of the following are present: 1

  • Abscess formation at the generator site
  • Device erosion through the skin
  • Skin adherence to the device
  • Chronic draining sinus tract
  • Purulent drainage from the pocket

Bacteremia-Related Criteria

  • Occult staphylococcal bacteremia (S. aureus or coagulase-negative staphylococci) without other identified source 1
  • Relapsing Gram-negative bacteremia despite appropriate antibiotics with no other defined focus 1
  • Persistent Gram-negative bacteremia despite appropriate antibiotics with no other source identified 1
  • Valvular endocarditis even without definite lead involvement 1

High-Risk Bacteremia Scenarios

ICD removal should be strongly considered when S. aureus bacteremia occurs with: 1

  • Relapsing bacteremia after appropriate antibiotic therapy
  • No other identified source for bacteremia
  • Bacteremia persisting >24 hours
  • Presence of a prosthetic cardiac valve
  • Bacteremia within 3 months of device placement

Important caveat: Gram-negative bacteremia alone without relapse or persistence does NOT require ICD removal, as infection is unlikely in this scenario. 1

Non-Infectious Indications

End-of-Life Care (Class I Recommendations)

  • ICD shock therapy deactivation (not removal) is appropriate when consistent with patient goals and preferences in: 1
    • Refractory heart failure symptoms
    • Refractory sustained ventricular arrhythmias
    • Terminal illness from other causes
  • Patients should be informed at implantation and during advance care planning that shock therapy can be deactivated at any time 1

Device Malfunction or Upgrade

  • Non-infectious device complications requiring replacement
  • Critical point: Do NOT obtain routine microbiological cultures during removal for non-infectious reasons, as contamination frequently yields false-positive results that lead to inappropriate antibiotic use 1

Situations Where Removal is NOT Indicated (Class III)

  • Superficial or incisional infection without device/lead involvement 1
  • Relapsing bloodstream infection from a source other than the ICD requiring long-term suppressive antibiotics 1
  • Isolated Gram-negative bacteremia without relapse or persistence 1

Post-Removal Management Algorithm

Antimicrobial Therapy Duration

  • Pocket infection only: 10-14 days after device removal 1
  • Bloodstream infection: At least 14 days after device removal 1
  • Complicated infection (endocarditis, septic thrombophlebitis, osteomyelitis, or persistent bacteremia): 4-6 weeks 1

Timing of Reimplantation

Before reimplanting, assess whether the patient still requires device therapy—one-third to one-half of patients may not need reimplantation due to resolved indications. 1

Blood culture requirements: 1

  • Repeat blood cultures must be negative for at least 72 hours before new device placement
  • For valvular infection: delay reimplantation for at least 14 days after first negative blood culture 1

Site selection: 1

  • Reimplant on the contralateral side whenever possible to avoid relapsing infection
  • Alternative sites include iliac vein or epicardial placement if contralateral approach not feasible

Bridging Strategy for Pacing-Dependent Patients

  • Wearable cardioverter-defibrillator is reasonable for patients with history of sudden cardiac arrest or sustained ventricular arrhythmia requiring temporary ICD removal due to infection (Class IIa) 1, 2
  • Active-fixation leads connected to external pacing generators can serve as a bridge until reimplantation 1

Common Pitfalls

  • Attempting conservative management with antibiotics alone results in 100% relapse rates and must be avoided 3, 4
  • Incomplete lead removal significantly increases risk of recurrent infection—all leads must be extracted, not just the generator 3, 4
  • Premature reimplantation before adequate blood culture clearance leads to treatment failure 1
  • Underestimating infection extent—apparent pocket infections may involve leads or endocardium, requiring transesophageal echocardiography for complete evaluation 3
  • Obtaining cultures during non-infectious removals leads to false-positive results and inappropriate management 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Wearable Cardioverter-Defibrillator Use and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Infected Abdominal Pacemaker Pocket

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Infected Pacemaker Pocket

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.